US Broker Ratings

GH Research PLC (GHRS) Stock Analysis: A Biotech with 169% Potential Upside

GH Research PLC (NASDAQ: GHRS), a promising contender in the healthcare sector, specifically in biotechnology, offers a unique proposition for investors seeking exposure to innovative treatments in mental health. Based..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A Biotech with a 125% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) has been gaining attention in the biotech sector as a clinical-stage biopharmaceutical company that focuses on developing precision medicines for kidney and metabolic diseases. With..

Talkspace, Inc. (TALK) Stock Analysis: High Revenue Growth and a Promising 18.73% Potential Upside

Talkspace, Inc. (TALK), a prominent player in the virtual behavioral healthcare sector, is capturing investor attention with its robust revenue growth and significant potential upside. With a current market capitalization..

AMN Healthcare Services Inc (AMN) Stock Analysis: Unlocking a Potential 22% Upside in the Healthcare Sector

AMN Healthcare Services Inc (AMN), a significant player in the healthcare staffing and workforce solutions sector, commands investor attention with its robust operational framework and promising growth potential. Based in..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating the 21.62% Potential Upside Amidst Challenges

Community Health Systems, Inc. (NYSE: CYH) is a significant player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $410.33 million,..

Orthofix Medical Inc. (OFIX) Investor Outlook: Unveiling a 49.61% Upside Potential

Investors looking for opportunities in the medical device sector may find Orthofix Medical Inc. (NASDAQ: OFIX) an intriguing prospect. Headquartered in Lewisville, Texas, this healthcare company operates globally, focusing on..

Inventiva S.A. (IVA): Analyst Ratings Signal Significant Upside Potential for Biotech Innovator

Inventiva S.A. (NASDAQ: IVA), a burgeoning player in the biotechnology sector, is capturing investor attention with its robust growth potential and promising pipeline. Headquartered in Daix, France, the company operates..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential Upside of Over 218% with a Focus on Kidney Disease Treatments

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is gaining attention from investors, particularly those interested in the healthcare sector’s drug manufacturing niche. As a biopharmaceutical company headquartered in Cambridge, Massachusetts, Akebia is..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Unveiling a 52.51% Potential Upside for Investors

Amylyx Pharmaceuticals, Inc. (AMLX), a Cambridge, Massachusetts-based clinical-stage pharmaceutical company, is making waves in the healthcare sector, specifically in the niche of drug manufacturers specializing in both specialty and generic..

Arbutus Biopharma (ABUS) Stock Analysis: Evaluating a 25% Upside Potential in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector with its focus on developing innovative therapeutics for infectious diseases. Headquartered in Warminster, Pennsylvania, this clinical-stage biopharmaceutical..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring Growth Potential and Analyst Consensus with a Promising 17.76% Upside

AxoGen, Inc. (AXGN) stands as a compelling player in the healthcare sector, specifically within the medical devices industry. As a company dedicated to the development and commercialization of technologies for..

Nuvation Bio Inc. (NUVB) Stock Analysis: Explosive 162% Upside Potential Amid Robust Revenue Growth

Nuvation Bio Inc. (NASDAQ: NUVB), a burgeoning entity in the biotechnology sector, has captured investor attention with its remarkable 162% potential upside, offering a compelling narrative for those seeking high-reward..

Claritev Corporation (CTEV) Stock Analysis: Exploring a 144.85% Potential Upside in Health Information Services

Claritev Corporation (NASDAQ: CTEV) offers an intriguing prospect for investors with a potential upside of 144.85% based on its average target price of $42.75. This healthcare-focused company, renowned for its..

Immatics N.V. (IMTX) Stock Analysis: Exploring an 81% Upside in Cancer Immunotherapy

Immatics N.V. (NASDAQ: IMTX), a German biotechnology firm, is making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in T cell redirecting immunotherapies, Immatics is..

Akso Health Group (AHG) Stock Analysis: Navigating Through Challenges in the Healthcare Sector

Akso Health Group (NASDAQ: AHG), a prominent player in the healthcare sector in China, has been drawing attention with its distinctive approach to medical distribution and e-commerce. Despite its innovative..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 136% Upside for Investors

Definitive Healthcare Corp. (NASDAQ: DH) operates within the dynamic Health Information Services industry, providing a comprehensive software-as-a-service (SaaS) healthcare commercial intelligence platform. With a market cap of $112.83 million, the..

Tilray Brands, Inc. (TLRY): Investor Outlook on a Cannabis Leader with 70% Upside Potential

Tilray Brands, Inc. (NASDAQ: TLRY) has become a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Leamington, Canada, Tilray operates on..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech with Nearly 99% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector. Specializing in the development of therapies for central nervous system (CNS) disorders, Praxis..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: 67.86% Upside Potential and Biotech Innovations

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands out in the biotechnology sector, offering promising avenues for investors seeking growth opportunities in groundbreaking medical treatments. Based in San Diego, California, Capricor is..

Embecta Corp. (EMBC) Stock Analysis: Is an 88% Upside in Sight for This Healthcare Innovator?

Embecta Corp. (NASDAQ: EMBC), a pivotal player in the healthcare sector, is capturing attention with a potential upside of 88.32%, making it a compelling option for investors seeking value in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds